Skip to main content
. Author manuscript; available in PMC: 2018 Jan 4.
Published in final edited form as: Pharm Res. 2017 Sep 5;34(11):2371–2384. doi: 10.1007/s11095-017-2244-x

Table I.

Characteristics of Docetaxel Liposome Formulation and the Corresponding Placebo

Formulation Particle size (nm) Polydispersity Zeta potential (mV) Entrapment efficiency (%)
Blank liposomes (without DTX and pshPFKFB3)   87.3 ± 2.3 0.204 ± 0.009 +21.6 ± 1.9
DTX liposomes (From DoE)   91.2 ± 9.4 0.269 ± 0.012 +22.3 ± 1.8 87.3 ± 2.6
DL 105.6 ± 7.4 0.265 ± 0.021 +17.8 ± 2.2 89.7 ± 4.1
PSH-DL 110.3 ± 8.3 0.285 ± 0.019 +18.5 ± 0.9 88.9 ± 3.4